144 related articles for article (PubMed ID: 10208302)
1. Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.
Bigoni R; Giuliani S; Calo' G; Rizzi A; Guerrini R; Salvadori S; Regoli D; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):160-7. PubMed ID: 10208302
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
[TBL] [Abstract][Full Text] [Related]
3. A new selective antagonist of the nociceptin receptor.
Guerrini R; Calo G; Rizzi A; Bigoni R; Bianchi C; Salvadori S; Regoli D
Br J Pharmacol; 1998 Jan; 123(2):163-5. PubMed ID: 9489602
[TBL] [Abstract][Full Text] [Related]
4. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of nociceptin receptor: an in vitro study.
Calò G; Rizzi A; Bodin M; Neugebauer W; Salvadori S; Guerrini R; Bianchi C; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):713-8. PubMed ID: 9276153
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
7. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
Rizzi D; Bigoni R; Rizzi A; Jenck F; Wichmann J; Guerrini R; Regoli D; Calo G
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):551-5. PubMed ID: 11383716
[TBL] [Abstract][Full Text] [Related]
8. Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens.
Bigoni R; Calo G; Guerrini R; Strupish JW; Rowbotham DJ; Lambert DG
Br J Clin Pharmacol; 2001 Apr; 51(4):355-8. PubMed ID: 11318773
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay.
Calò G; Rizzi A; Marzola G; Guerrini R; Salvadori S; Beani L; Regoli D; Bianchi C
Br J Pharmacol; 1998 Sep; 125(2):373-8. PubMed ID: 9786511
[TBL] [Abstract][Full Text] [Related]
10. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain.
Bertorelli R; Corradini L; Rafiq K; Tupper J; Calò G; Ongini E
Br J Pharmacol; 1999 Nov; 128(6):1252-8. PubMed ID: 10578139
[TBL] [Abstract][Full Text] [Related]
11. Supraspinal and spinal effects of [Phe1psi(CH2-NH)Gly2]-nociceptin(1-13)-NH2 on nociception in the rat.
Candeletti S; Guerrini R; Calò G; Romualdi P; Ferri S
Life Sci; 2000; 66(3):257-64. PubMed ID: 10666001
[TBL] [Abstract][Full Text] [Related]
12. The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro.
Chu X; Xu N; Li P; Wang JQ
Eur J Pharmacol; 1999 Jan; 364(1):49-53. PubMed ID: 9920184
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.
Bigoni R; Rizzi D; Rizzi A; Camarda V; Guerrini R; Lambert DG; Hashiba E; Berger H; Salvadori S; Regoli D; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):442-9. PubMed ID: 12070757
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice.
Rizzi A; Bigoni R; Marzola G; Guerrini R; Salvadori S; Regoli D; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):161-5. PubMed ID: 11218068
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.
Calo' G; Guerrini R; Bigoni R; Rizzi A; Bianchi C; Regoli D; Salvadori S
J Med Chem; 1998 Aug; 41(18):3360-6. PubMed ID: 9719588
[TBL] [Abstract][Full Text] [Related]
16. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus.
Rizzi A; Calò G; Trevisani M; Tognetto M; Fabbri L; Mapp C; Guerrini R; Salvadori S; Regoli D; Geppetti P
Life Sci; 1999; 64(13):PL157-63. PubMed ID: 10210279
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
Bigoni R; Calo' G; Rizzi A; Guerrini R; De Risi C; Hashimoto Y; Hashiba E; Lambert DG; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):565-8. PubMed ID: 10832612
[TBL] [Abstract][Full Text] [Related]
19. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord.
Xu IS; Wiesenfeld-Hallin Z; Xu XJ
Neurosci Lett; 1998 Jun; 249(2-3):127-30. PubMed ID: 9682833
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.
Siniscalchi A; Rodi D; Beani L; Bianchi C
Br J Pharmacol; 1999 Sep; 128(1):119-23. PubMed ID: 10498842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
